EpiTherapeutics is a biopharmaceutical company developing novel innovative cancer drugs based on the world leading research in the field of epigenetics. EpiTherapeutics' development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. EpiTherapeutics is based in Denmark.


Latest News Entry
Gilead Sciences Acquires EpiTherapeutics

Gilead Sciences, Inc. and EpiTherapeutics ApS, a privately-held Danish company, announced the signing of a definitive agreement pursuant ...

all portfolio news